Why Does the World Continue to Struggle with Preventable Patient Harm?

 

Patient safety is something every healthcare organization wants to improve upon, especially with the shift to value-based care. However, most are missing the mark with preventable patient harm and truly being patient-centric. Discussing the topic today, B2B Today host Daniel Litwin spoke with Dr. Donna Prosser, Chief Clinical Officer of the Patient Safety Movement Foundation, a nonprofit that’s goal to reach zero preventable patient harm and deaths. The company will host the #UniteForSafeCare event on World Patient Day on September 17.

“There had been success in improving patient safety, but that fell apart during COVID because there was a hyper-focus. It comes down to the lack of a high-reliability foundation,” Dr. Prosser noted.

“Hospitals are businesses and concerned about public image and marketability. That sustains a culture of silence where no one talks about the issues.” – Dr. Donna Prosser

Dr. Prosser argued that while organizations say they are patient-focused, the processes and structure of healthcare is clinician-focused. That could be why some clinicians seem to make numerous errors undetected, as seen in the upcoming TV show Dr. Death, which centers on a real neurosurgeon’s medical incompetence.

“This is at the far end of the spectrum, but other situations happen regularly because of the way the system is set up. Transparency, openness, and trust aren’t there. People saw this behavior and didn’t feel comfortable voicing it or hit a wall if they did,” Dr. Prosser explained.

This “culture of silence” is what perpetuates preventable patient harm. That’s reflected in research. One survey found that 6% of patients were affected, while another from the World Health Organization (WHO) found that four in 10 patients suffered some harm.

So, what’s the answer to address preventable harm? Dr. Prosser said, “No one can do it alone. All stakeholders have to be at the table. We have to band together, shine a light on it, address it, and create those highly reliable systems. It will require culture change.”

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More